Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Clinical trial NCT00704288 · COMPLETED

Trial details

NCT number: NCT00704288
Sponsor: Exelixis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2008-05-01
Primary completion: 2012-06-01
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.